Chorionic Gonadotropin Purple Book BLA 017067

BLA number
017067
Proprietary names
Chorionic Gonadotropin
Proper names
chorionic gonadotropin
Applicant
Fresenius Kabi USA, LLC
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Chorionic Gonadotropinchorionic gonadotropin351(a)5,000UNITSFor InjectionIntramuscularMulti-Dose VialDiscLicensed1973-03-05
002Chorionic Gonadotropinchorionic gonadotropin351(a)10,000UNITSFor InjectionIntramuscularMulti-Dose VialRxLicensed1973-03-05
003Chorionic Gonadotropinchorionic gonadotropin351(a)15,0000UNITSFor InjectionIntramuscularMulti-Dose VialDiscLicensed1973-03-05
004Chorionic Gonadotropinchorionic gonadotropin351(a)20,000UNITSFor InjectionIntramuscularMulti-Dose VialDiscLicensed1973-03-05

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2020-05-01R001Chorionic Gonadotropin351(a)DiscFresenius Kabi USA, LLC
2020-05-01R002Chorionic Gonadotropin351(a)RxFresenius Kabi USA, LLC
2020-05-01R003Chorionic Gonadotropin351(a)DiscFresenius Kabi USA, LLC
2020-05-01R004Chorionic Gonadotropin351(a)DiscFresenius Kabi USA, LLC

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2020-05-01001Chorionic Gonadotropin351(a)DiscLicensed1973-03-05
2020-05-01002Chorionic Gonadotropin351(a)RxLicensed1973-03-05
2020-05-01003Chorionic Gonadotropin351(a)DiscLicensed1973-03-05
2020-05-01004Chorionic Gonadotropin351(a)DiscLicensed1973-03-05